Generalised linear mixed regression analysis to determine the effect of MTX pause on neutralising capacity
| β | 95% CI | P value | |
| Wuhan | |||
| TBV | 112.32 | −430.95 to 206.31 | 0.490 |
| TAV | 228.78 | 3.24 to 454.32 | 0.047 |
| TBV+TAV | 91.45 | −2.97 to 185.87 | 0.058 |
| BA.1 | |||
| TBV | −24.90 | −100.14 to 50.33 | 0.516 |
| TAV | 53.44 | 0.19 to 106.69 | 0.049 |
| TBV+TAV | 21.92 | −0.31 to 44.15 | 0.053 |
| BA.2 | |||
| TBV | 140.03 | −310.16 to 30.10 | 0.107 |
| TAV | 178.62 | 58.53 to 298.72 | 0.004 |
| TBV+TAV | 50.52 | −0.64 to 101.67 | 0.053 |
MTX, methotrexate; TAV, time after vaccination; TBV, time before vaccination.